Résumé
•No significant differences in serum β-lactam concentrations between extracorporeal membrane oxygenation (ECMO) and non-ECMO patients were found in this study.•No significant differences in volume of distribution or drug elimination were observed in these two groups.•One-third of ECMO patients had insufficient drug concentrations to treat Pseudomonas aeruginosa.•Insufficient drug concentrations were more frequent with piperacillin/tazobactam than meropenem therapy.
Most adult patients receiving extracorporeal membrane oxygenation (ECMO) require antibiotic therapy, however the pharmacokinetics of β-lactams have not been well studied in these conditions. In this study, data from all patients receiving ECMO support and meropenem (MEM) or piperacillin/tazobactam (TZP) were reviewed. Drug concentrations were measured 2h after the start of a 30-min infusion and just before the subsequent dose. Therapeutic drug monitoring (TDM) results in ECMO patients were matched with those in non-ECMO patients for (i) drug regimen, (ii) renal function, (iii) total body weight, (iv) severity of organ dysfunction and (v) age. Drug concentrations were considered adequate if they remained 4–8× the clinical MIC breakpoint for Pseudomonas aeruginosa for 50% (TZP) or 40% (MEM) of the dosing interval. A total of 41 TDM results (27 MEM; 14 TZP) were obtained in 26 ECMO patients, with 41 matched controls. There were no significant differences in serum concentrations or pharmacokinetic parameters between ECMO and non-ECMO patients, including Vd [0.38 (0.27–0.68) vs. 0.46 (0.33–0.79)L/kg; P=0.37], half-life [2.6 (1.8–4.4) vs. 2.9 (1.7–3.7)h; P=0.96] and clearance [132 (66–200) vs. 141 (93–197)mL/min; P=0.52]. The proportion of insufficient (13/41 vs. 12/41), adequate (15/41 vs. 19/41) and excessive (13/41 vs. 10/41) drug concentrations was similar in ECMO and non-ECMO patients. Achievement of target concentrations of these β-lactams was poor in ECMO and non-ECMO patients. The influence of ECMO on MEM and TZP pharmacokinetics does not appear to be significant.